Original Research Online Publishing Date: | ||||||||||||
Prevalence, severity, and trends in drug therapy of COVID-19 breakthrough infection at L-3 COVID Hospital, Bareilly: A cross-sectional study Anju Saxena, Iram Shaifali, Shalini Chandra, Manohar Yazali.
|
How to Cite this Article |
Pubmed Style Saxena A, Shaifali I, Chandra S, Yazali M. Prevalence, severity, and trends in drug therapy of COVID-19 breakthrough infection at L-3 COVID Hospital, Bareilly: A cross-sectional study. Natl J Physiol Pharm Pharmacol. 2022; 12(12): 2110-2114. doi:10.5455/njppp.2022.12.04190202209052022 Web Style Saxena A, Shaifali I, Chandra S, Yazali M. Prevalence, severity, and trends in drug therapy of COVID-19 breakthrough infection at L-3 COVID Hospital, Bareilly: A cross-sectional study. https://www.njppp.com/?mno=26571 [Access: March 14, 2024]. doi:10.5455/njppp.2022.12.04190202209052022 AMA (American Medical Association) Style Saxena A, Shaifali I, Chandra S, Yazali M. Prevalence, severity, and trends in drug therapy of COVID-19 breakthrough infection at L-3 COVID Hospital, Bareilly: A cross-sectional study. Natl J Physiol Pharm Pharmacol. 2022; 12(12): 2110-2114. doi:10.5455/njppp.2022.12.04190202209052022 Vancouver/ICMJE Style Saxena A, Shaifali I, Chandra S, Yazali M. Prevalence, severity, and trends in drug therapy of COVID-19 breakthrough infection at L-3 COVID Hospital, Bareilly: A cross-sectional study. Natl J Physiol Pharm Pharmacol. (2022), [cited March 14, 2024]; 12(12): 2110-2114. doi:10.5455/njppp.2022.12.04190202209052022 Harvard Style Saxena, A., Shaifali, . I., Chandra, . S. & Yazali, . M. (2022) Prevalence, severity, and trends in drug therapy of COVID-19 breakthrough infection at L-3 COVID Hospital, Bareilly: A cross-sectional study. Natl J Physiol Pharm Pharmacol, 12 (12), 2110-2114. doi:10.5455/njppp.2022.12.04190202209052022 Turabian Style Saxena, Anju, Iram Shaifali, Shalini Chandra, and Manohar Yazali. 2022. Prevalence, severity, and trends in drug therapy of COVID-19 breakthrough infection at L-3 COVID Hospital, Bareilly: A cross-sectional study. National Journal of Physiology, Pharmacy and Pharmacology, 12 (12), 2110-2114. doi:10.5455/njppp.2022.12.04190202209052022 Chicago Style Saxena, Anju, Iram Shaifali, Shalini Chandra, and Manohar Yazali. "Prevalence, severity, and trends in drug therapy of COVID-19 breakthrough infection at L-3 COVID Hospital, Bareilly: A cross-sectional study." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 2110-2114. doi:10.5455/njppp.2022.12.04190202209052022 MLA (The Modern Language Association) Style Saxena, Anju, Iram Shaifali, Shalini Chandra, and Manohar Yazali. "Prevalence, severity, and trends in drug therapy of COVID-19 breakthrough infection at L-3 COVID Hospital, Bareilly: A cross-sectional study." National Journal of Physiology, Pharmacy and Pharmacology 12.12 (2022), 2110-2114. Print. doi:10.5455/njppp.2022.12.04190202209052022 APA (American Psychological Association) Style Saxena, A., Shaifali, . I., Chandra, . S. & Yazali, . M. (2022) Prevalence, severity, and trends in drug therapy of COVID-19 breakthrough infection at L-3 COVID Hospital, Bareilly: A cross-sectional study. National Journal of Physiology, Pharmacy and Pharmacology, 12 (12), 2110-2114. doi:10.5455/njppp.2022.12.04190202209052022 |